Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein

References

• Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications. Diabetes 1999; 48: 1–9
   PubMed Web of Science ®Google Scholar
• Karpen C.W., Cataland S., O'Dorisio T.M., Panganamala R.V. Interrelation of platelet vitamin E and thromboxane synthesis in type I diabetes mellitus. Diabetes 1984; 33: 239–243
   PubMed Web of Science ®Google Scholar
• Som S., Basu S., Mukherjee D., Deb S., Choudhury P.R., Mukherjee S., Chatterjee S.N., Chatterjee I.B. Ascorbic acid metabolism in diabetes mellitus. Metabolism 1981; 30: 572–577
   PubMed Web of Science ®Google Scholar
• Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New England Journal of Medicine 1988; 318: 1315–1321
   PubMed Web of Science ®Google Scholar
• Bucala R., Cerami A. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Advances in Pharmacology 1992; 23: 1–34
   PubMedGoogle Scholar
• Schleicher E., Deufel T., Wieland O.H. Non-enzymatic glycosylation of human serum lipoproteins. Elevated epsilon-lysine glycosylated low density lipoprotein in diabetic patients. FEBS Letters 1981; 129: 1–4
   PubMed Web of Science ®Google Scholar
• Bucala R., Makita Z., Koschinsky T., Cerami A., Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proceedings of the Natlional Academy of Sciences of the USA 1993; 90: 6434–6438
   PubMed Web of Science ®Google Scholar
• Berg T.J., Nourooz Zadeh J., Wolff S.P., Tritschler H.J., Bangstad H.J., Hanssen K.F. Hydroperoxides in plasma are reduced by intensified insulin treatment. A randomized controlled study of IDDM patients with microalbuminuria. Diabetes Care 1998; 21: 1295–1300
   PubMedGoogle Scholar
• Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999; 48: 937–942
   PubMed Web of Science ®Google Scholar
• Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New England Journal of Medicine 1989; 320: 915–924
   PubMed Web of Science ®Google Scholar
• Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. Journal of Biological Chemistry 1997; 272: 20963–20966
   PubMed Web of Science ®Google Scholar
• Steinberg D. Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997; 95: 1062–1071
   PubMed Web of Science ®Google Scholar
• Witztum J.L., Mahoney E.M., Branks M.J., Fisher M., Elam R., Steinberg D. Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes 1982; 31: 283–291
   PubMed Web of Science ®Google Scholar
• Hunt J.V., Smith C.C., Wolff S.P. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 1990; 39: 1420–1424
   PubMed Web of Science ®Google Scholar
• Millican S.A., Schultz D., Bagga M., Coussons P.J., Muller K., Hunt J.V. Glucose-modified low density lipoprotein enhances human monocyte chemotaxis. Free Radical Research 1998; 28: 533–542
   PubMed Web of Science ®Google Scholar
• Fotsis T., Pepper M., Adlercreutz H., Fleischmann G., Hase T., Montesano R., Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proceedings of the National Academy of Sciences of the USA 1993; 90: 2690–2694
   PubMed Web of Science ®Google Scholar
• Fotsis T., Pepper M., Adlercreutz H., Hase T., Montesano R., Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. Journal of Nutrition 1995; 125: 790S–797S
   PubMed Web of Science ®Google Scholar
• Kapiotis S., Hermann M., Held I., Seelos C., Ehringer H., Gmeiner B.M. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arteriosclerosis, Thrombosis and Vascular Biology 1997; 17: 2868–2874
   PubMed Web of Science ®Google Scholar
• Hermann M., Gmeiner B. Altered susceptibility to in vitro oxidation of LDL in LDL complexes and LDL aggregates. Arteriosclerosis and Thrombosis 1992; 12: 1503–1506
   PubMed Web of Science ®Google Scholar
• Kapiotis S., Besemer J., Bevec D., Valent P., Bettelheim P., Lechner K., Speiser W. Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells. Blood 1991; 78: 410–415
   PubMed Web of Science ®Google Scholar
• el Saadani M., Esterbauer H., el Sayed M., Goher M., Nassar A.Y., Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. Journal of Lipid Research 1989; 30: 627–630
   PubMed Web of Science ®Google Scholar
• Wallin B., Camejo G. Lipoprotein oxidation and measurement of hydroperoxide formation in a single microtitre plate. Scandinavian Journal of Clinical and Laboratory Investigation 1994; 54: 341–346
   PubMed Web of Science ®Google Scholar
• Hermann M., Kapiotis S., Hofbauer R., Exner M., Seelos C., Held I., Gmeiner B. Salicylate inhibits LDL oxidation initiated by superoxide/nitric oxide radicals. FEBS Letters 1999; 445: 212–214
   PubMed Web of Science ®Google Scholar
• Steinbrecher U.P., Witztum J.L., Parthasarathy S., Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis 1987; 7: 135–143
   PubMedGoogle Scholar
• Drake T.A., Hannani K., Fei H.H., Lavi S., Berliner J.A. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. American Journal of Pathology 1991; 138: 601–607
   PubMed Web of Science ®Google Scholar
• Giessauf A., Steiner E., Esterbauer H. Early destruction of tryptophan residues of apolipoprotein B is a vitamin E-independent process during copper-mediated oxidation of LDL. Biochimica and Biophysica Acta 1995; 1256: 221–232
   PubMed Web of Science ®Google Scholar
• Giessauf A., van Wickern B., Simat T., Steinhart H., Esterbauer H. Formation of N-formylkynurenine suggests the involvement of apolipoprotein B-100 centered tryptophan radicals in the initiation of LDL lipid peroxidation. FEBS Letters 1996; 389: 136–140
   PubMed Web of Science ®Google Scholar
• Horakova L., Giessauf A., Raber G., Esterbauer H. Effect of stobadine on Cu(++)-mediated oxidation of low-density lipoprotein. Biochemical Pharmacology 1996; 51: 1277–1282
   PubMed Web of Science ®Google Scholar
• Wolff S.P., Dean R.T. Glucose autoxidation and protein modification. The potential role of autoxidative glycosylation' in diabetes. Biochemical Journal 1987; 245: 243–250
   PubMed Web of Science ®Google Scholar
• Wolff S.P., Jiang Z.Y., Hunt J.V. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radical Biology & Medicine 1991; 10: 339–352
   PubMed Web of Science ®Google Scholar
• Jiang Z.Y., Woollard A.C., Wolff S.P. Hydrogen peroxide production during experimental protein glycation. FEBS Letters 1990; 268: 69–71
   PubMed Web of Science ®Google Scholar
• Fei H., Berliner J.A., Parhami F., Drake T.A. Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arteriosclerosis and Thrombosis 1993; 13: 1711–1717
   PubMed Web of Science ®Google Scholar
• Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radical Biology & Medicine 1991; 11: 81–128
   PubMed Web of Science ®Google Scholar
• Simionescu M., Simionescu N. Proatherosclerotic events: pathobiochemical changes occurring in the arterial wall before monocyte migration. FASEB Journal 1993; 7: 1359–1366
   PubMed Web of Science ®Google Scholar
• Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., Watson A.D., Lusis A.J. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91: 2488–2496
   PubMed Web of Science ®Google Scholar
• Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radical Biology & Medicine 1996; 20: 707–727
   PubMed Web of Science ®Google Scholar
• Galle J., Schneider R., Winner B., Lehmann Bodem C., Schinzel R., Munch G., Conzelmann E., Wanner C. Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress. Atherosclerosis 1998; 138: 65–77
   PubMedGoogle Scholar
• Posch K., Simecek S., Wascher T.C., Jurgens G., Baumgartner Parzer S., Kostner G.M., Graier W.F. Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells. Diabetes 1999; 48: 1331–1337
   PubMed Web of Science ®Google Scholar
• Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998; 141: 1–15
   PubMed Web of Science ®Google Scholar
• Morel D.W., Chisolm G.M. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. Journal of Lipid Research 1989; 30: 1827–1834
   PubMed Web of Science ®Google Scholar
• Stocker R. Dietary and pharmacological antioxidants in atherosclerosis. Current Opinion in Lipidology 1999; 10: 589–597
   PubMed Web of Science ®Google Scholar
• Catapano A.L. Antioxidant effect of flavonoids. Angiology 1997; 48: 39–44
   PubMed Web of Science ®Google Scholar
• Cotelle N., Bernier J.L., Catteau J.P., Pommery J., Wallet J.C., Gaydou E.M. Antioxidant properties of hydroxy-flavones. Free Radical Biology & Medicine 1996; 20: 35–43
   PubMed Web of Science ®Google Scholar
• van Acker S.A., van den Berg D.J., Tromp M.N., Griffioen D.H., van Bennekom W.P., van der Vijgh W.J., Bast A. Structural aspects of antioxidant activity of flavonoids. Free Radical Biology & Medicine 1996; 20: 331–342
   PubMed Web of Science ®Google Scholar
• Miller N.J., Castelluccio C., Tijburg L., Rice Evans C. The antioxidant properties of theaflavins and their gallate esters—radical scavengers or metal chelators?. FEBS Letters 1996; 392: 40–44
   PubMed Web of Science ®Google Scholar
• Vaya J., Belinky P.A., Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radical Biology & Medicine 1997; 23: 302–313
   PubMed Web of Science ®Google Scholar
• Frankel E.N., Kanner J., German J.B., Parks E., Kinsella J.E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454–457
   PubMed Web of Science ®Google Scholar
• Vinson J.A., Dabbagh Y.A. Effect of green and black tea supplementation on lipids, lipid oxidation and fibrinogen in the hamster: mechanisms for the epidemiological benefits of tea drinking. FEBS Letters 1998; 433: 44–46
   PubMedGoogle Scholar
• Lean M.E., Noroozi M., Kelly I., Burns J., Talwar D., Sattar N., Crozier A. Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. Diabetes 1999; 48: 176–181
   PubMed Web of Science ®Google Scholar
• Ruiz Larrea M.B., Mohan A.R., Paganga G., Miller N.J., Bolwell G.P., RiceEvans C.A. Antioxidant activity of phytoestrogenic isoflavones. Free Radical Research 1997; 26: 63–70
   PubMedGoogle Scholar
• Watanabe S., Yamaguchi M., Sobue T., Takahashi T., Miura T., Arai Y., Mazur W., Wahala K., Adlercreutz H. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). Journal of Nutrition 1998; 128: 1710–1715
   PubMed Web of Science ®Google Scholar
• King R.A., Bursill D.B. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. American Journal of Clinical Nutrition 1998; 67: 867–872
   PubMed Web of Science ®Google Scholar
• Ascherio A., Willett W.C. New directions in dietary studies of coronary heart disease. Journal of Nutrition 1995; 125: 647S–655S
   Google Scholar
• Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scandinavian Journal of Clinical and Laboratory Investigation (Supplement) 1990; 201: 3–23
   PubMedGoogle Scholar
• Tikkanen M.J., Wahala K., Ojala S., Vihma V., Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proceedings of the National Academy of Sciences of the USA 1998; 95: 3106–3110
   PubMed Web of Science ®Google Scholar
• Anderson J.W., Gowri M.S., Turner J., Nichols L., Diwadkar V.A., Chow C.K., Oeltgen P.R. Antioxidant supplementation effects on low-density lipoprotein oxidation for individuals with type 2 diabetes mellitus. Journal of the American College of Nutrition 1999; 18: 451–461
   PubMed Web of Science ®Google Scholar
• Halliwell B. The antioxidant paradox. Lancet 2000; 355: 1179–1180
   PubMed Web of Science ®Google Scholar